Developing an economic model to estimate the cost-effectiveness of first-line treatments for chronic myelogenous leukemia.

e17008 Background: Chronic myelogenous leukaemia (CML) is a progressive disease that is associated with significant health and economic burden. This study aims to develop an economic model to asses...